Arcturus Therapeutics Holdings, Inc. (ARCT)
15.19
-0.98
(-6.06%)
USD |
NASDAQ |
Aug 28, 16:00
15.18
-0.01
(-0.07%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Cash from Operations (Quarterly) : -20.92M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -20.92M |
| March 31, 2026 | -19.44M |
| December 31, 2025 | -18.08M |
| September 30, 2025 | -19.63M |
| June 30, 2025 | -5.926M |
| March 31, 2025 | -35.14M |
| December 31, 2024 | -0.4598M |
| September 30, 2024 | -23.83M |
| June 30, 2024 | -29.85M |
| March 31, 2024 | -5.557M |
| December 31, 2023 | -0.5447M |
| September 30, 2023 | -31.62M |
| June 30, 2023 | 50.57M |
| March 31, 2023 | -35.87M |
| December 31, 2022 | 155.17M |
| September 30, 2022 | -40.45M |
| June 30, 2022 | -34.88M |
| March 31, 2022 | -49.04M |
| December 31, 2021 | -45.14M |
| September 30, 2021 | -17.13M |
| June 30, 2021 | -33.07M |
| March 31, 2021 | -42.95M |
| December 31, 2020 | -7.393M |
| September 30, 2020 | -16.53M |
| June 30, 2020 | -8.457M |
| Date | Value |
|---|---|
| March 31, 2020 | -11.86M |
| December 31, 2019 | -7.691M |
| September 30, 2019 | -2.838M |
| June 30, 2019 | 9.366M |
| March 31, 2019 | -5.411M |
| December 31, 2018 | -5.482M |
| September 30, 2018 | -6.599M |
| June 30, 2018 | -7.709M |
| March 31, 2018 | -0.361M |
| December 31, 2017 | 10.11M |
| September 30, 2017 | -1.403M |
| June 30, 2017 | -4.211M |
| March 31, 2017 | -4.964M |
| December 31, 2016 | -3.90M |
| September 30, 2016 | -6.734M |
| June 30, 2016 | -4.207M |
| March 31, 2016 | -4.437M |
| December 31, 2015 | -4.156M |
| September 30, 2015 | -5.458M |
| June 30, 2015 | -3.975M |
| March 31, 2015 | -4.595M |
| December 31, 2014 | -6.020M |
| September 30, 2014 | -9.298M |
| June 30, 2014 | -5.518M |
| March 31, 2014 | -5.628M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Exelixis, Inc. | 307.74M |
| PTC Therapeutics, Inc. | 129.11M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
| Anika Therapeutics, Inc. | -0.684M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.0193M |
| Cash from Financing (Quarterly) | 0.0004M |
| Free Cash Flow | -78.18M |
| Free Cash Flow Per Share (Quarterly) | -0.736 |
| Free Cash Flow to Equity (Quarterly) | -19.87M |
| Free Cash Flow to Firm (Quarterly) | -20.92M |
| Free Cash Flow Yield | -18.36% |